DOI QR코드

DOI QR Code

Association of Body Mass Index and Cognitive Function in Alzheimer's Disease and Mild Cognitive Impairment

알츠하이머병과 경도인지장애에서 체질량지수와 인지기능과의 연관성

  • Lim, Eun Jeong (Department of Psychiatry, Ilsan Paik Hospital, Inje University College of Medicine) ;
  • Lee, Kang Joon (Department of Psychiatry, Ilsan Paik Hospital, Inje University College of Medicine) ;
  • Kim, Hyun (Department of Psychiatry, Ilsan Paik Hospital, Inje University College of Medicine)
  • 임은정 (인제대학교 의과대학 일산백병원 정신건강의학교실) ;
  • 이강준 (인제대학교 의과대학 일산백병원 정신건강의학교실) ;
  • 김현 (인제대학교 의과대학 일산백병원 정신건강의학교실)
  • Received : 2016.09.24
  • Accepted : 2016.12.14
  • Published : 2016.12.31

Abstract

Objectives : This study analyzed the differences of body mass index(BMI) in Korean patients with Alzheimer's diseases(AD), Mild Cognitive Impairment(MCI), and healthy controls to verify whether low BMI is associated with cognitive impairment. Furthermore, this study also sought to examine any association between BMI and Mini Mental State Examination-Korean version(MMSE-K), Clinical Dementia Rating(CDR), and Global Deterioration Scale(GDS). Methods : A total of 257 subjects were included in the study. History taking, mental status examination, physical examination and neurocognitive function test were carried out for the diagnosis of AD and MCI. The subjects' demographic data and presence of diseases were also surveyed. The overall cognitive function and severity of diseases were assessed using MMSE-K, GDS, and CDR. Results : The order of BMI was found to be healthy controls>MCI>AD, with statistically significant differences among the groups. The order of MMSE-K scores was similar, with healthy controls>MCI>AD in statistically significant differences. The healthy controls had the lowest CDR and GDS scores, and AD patients had the highest scores. There was a significant positive correlation between BMI and MMSE scores(r=0.238, p=0.000). BMI was negatively correlated with CDR(r=-0.174, p=0.008) as well as with GDS(r=-0.233, p= 0.000). Conclusions : Measuring BMI of patients with AD or MCI is expected to be meaningful in that BMI could be a clinical indicator of AD. We expect this to be beneficial for the diagnosis, prevention, and therapeutic approach of AD and also expect large-scale, long-term longitudinal studies to follow.

연구목적 본 연구는 알츠하이머병(Alzheimer's disease, AD), 경도인지장애(Mild Cognitive Impairment, MCI), 정상군에서 체질량지수(Body Mass Index, BMI)의 차이를 분석하여 낮은 BMI 수치와 인지기능 저하와의 연관을 확인하고자 하였다. 또한, 한국판 간이정신상태검사(Mini Mental State Examination-Korean version, MMSEK), 치매임상평가척도(Clinical Dementia Rating, CDR), 전반적 퇴화척도(Global Deterioration Scale, GDS)과 BMI 사이에 연관성이 있는지도 알아보고자 하였다. 방 법 총 257명의 연구대상자들이 이 연구에 포함되었고, AD 및 MCI 진단을 위해 병력 청취, 정신상태검사, 신경인지기능검사, 신체 검사가 시행되었다. 대상자의 성별 및 연령과 신체 질환도 함께 조사하였다. 전반적인 인지기능과 질병의 심각도 단계 평가는 MMSE-K, GDS, CDR으로 측정하였다. 결 과 MMSE-K 점수는 정상군>MCI>AD 순이었으며 통계적으로 유의한 차이를 나타내었다(p=0.000). CDR과 GDS점수는 정상군이 가장 높았고, AD군이 가장 낮았으며 역시 통계적으로 유의한 차이를 나타내었다 BMI와 MMSE 점수 사이에는 유의한 양의 상관관계가 있었다(r=0.238, p=0.000). BMI와 CDR과는 음의 상관관계를 나타내었으며(r=-0.174, p=0.008), BMI와 GDS 역시, 음의 상관관계를 보였다(r=-0.233, p=0.000). 결 론 BMI와 인지기능과의 연관성이 있으므로, 치매나 경도인지장애 환자를 대상으로 BMI를 측정하는 것은 임상적 표지자로서 의미가 있을 것으로 예상된다. 본 연구는 AD의 진단 및 예방, 그리고 치료적 접근에 도움을 줄 수 있을 것으로 기대하며, 향후 이에 대한 대규모의 장기 추적 연구가 필요할 것으로 생각된다.

Keywords

References

  1. Bagi Z. Mechanisms of coronary microvascular adaptation to obesity. Am J Physiol Regul Integr Comp Physiol 2009;297:556-567. https://doi.org/10.1152/ajpregu.90817.2008
  2. Rosengren A, Skoog I, Gustafson D, Wilhelmsen L. Body mass index, other cardiovascular risk factors, and hospitalization for dementia. Arch Intern Med 2005;165:321-326. https://doi.org/10.1001/archinte.165.3.321
  3. World Health Organization. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser 2000;894:1-253.
  4. Wang SY, Fukagawa N, Hossain M, Ooi WL. Longitudinal weight changes, length of survival, and energy requirements of long-term care residents with dementia. J Am Geriatr Soc 1997;45:1189-1195. https://doi.org/10.1111/j.1532-5415.1997.tb03768.x
  5. White H, Pieper C, Schmader K. The association of weight change in Alzheimer's disease with severity of disease and mortality: A longitudinal analysis. J Am Geriatr Soc 1998;46:1223-1227. https://doi.org/10.1111/j.1532-5415.1998.tb04537.x
  6. White H, Pieper C, Schmader K, Fillenbaum G. Weight change in Alzheimer's disease. J Am Geriatr Soc 1996;44:265-272. https://doi.org/10.1111/j.1532-5415.1996.tb00912.x
  7. Volicer L, Frijters DH, van der Steen JT. Apathy and weight loss in nursing home residents: longitudinal study. J Am Med Dir Assoc 2013;14:417-420. https://doi.org/10.1016/j.jamda.2012.12.004
  8. Anstey KJ, Cherbuin N, Budge M, Young J. Body mass index in midlife and late-life as a risk factor for dementia: A meta-analysis of prospective studies. Obes Rev 2011;12:426-437. https://doi.org/10.1111/j.1467-789X.2010.00825.x
  9. Burns JM, Johnson DK, Watts A, Swerdlow RH, Brooks WM. Reduced lean mass in early Alzheimer disease and its association with brain atrophy. Arch Neurol 2010;67:428-433.
  10. Buchman AS, Wilson RS, Bienias JL, Shah RC, Evans DA, Bennett DA. Change in body mass index and risk of incident Alzheimer disease. Neurology 2005;65:892-897. https://doi.org/10.1212/01.wnl.0000176061.33817.90
  11. Atti AR, Palmer K, Volpato S, Winblad B, De Ronchi D, Fratiglioni L. Late-life body mass index and dementia incidence: nine-year follow-up data from the Kungsholmen Project. J Am Geriatr Soc 2008;56:111-116. https://doi.org/10.1111/j.1532-5415.2007.01458.x
  12. Hughes TF, Borenstein AR, Schofield E, Wu Y, Larson EB. Association between late-life body mass index and dementia: The Kame Project. Neurology 2009;72:1741-1746. https://doi.org/10.1212/WNL.0b013e3181a60a58
  13. Power BD, Alfonso H, Flicker L, Hankey GJ, Yeap BB, Almeida OP. Changes in body mass in later life and incident dementia. Int Psychogeriatr 2013;25:467-478. https://doi.org/10.1017/S1041610212001834
  14. Tolppanen AM, Ngandu T, Kareholt I, Laatikainen T, Rusanen M, Soininen H, Kivipelto M. Midlife and late-life body mass index and late-life dementia: results from a prospective population-based cohort. J Alzheimers Dis 2014;38:201-209.
  15. Cronk BB, Johnson DK, Burns JM; Alzheimer's Disease Neuroimaging Initiative. Body mass index and cognitive decline in mild cognitive impairment. Alzheimer Dis Assoc Disord 2010;24:126-130. https://doi.org/10.1097/WAD.0b013e3181a6bf3f
  16. Besser LM, Gill DP, Monsell SE, Brenowitz W, Meranus DH, Kukull W, Gustafson DR. Body mass index, weight change, and clinical progression in mild cognitive impairment and Alzheimer disease. Alzheimer Dis Assoc Disord 2014;28:36-43. https://doi.org/10.1097/WAD.0000000000000005
  17. Luchsinger JA, Patel B, Tang MX, Schupf N, Mayeux R. Measures of adiposity and dementia risk in elderly persons. Arch Neurol 2007;64:392-398. https://doi.org/10.1001/archneur.64.3.392
  18. Nourhashemi F, Deschamps V, Larrieu S, Letenneur L, Dartigues JF, Barberger-Gateau P. Body mass index and incidence of dementia: The PAQUID study. Neurology 2003;60:117-119. https://doi.org/10.1212/01.WNL.0000038910.46217.AA
  19. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 1999;56:303-308. https://doi.org/10.1001/archneur.56.3.303
  20. Park JH, Kwon YC. Standardization of Korean Version of the Mini-Mental State Examination(MMSE-K) for Use in the Elderly. J Clin Psyhicatry 2012;73;1548-1554.
  21. Choi SH, Na DL, Lee BH, Hahm DS, Jeong JH, Yoon SJ, Hahn DS, Yoo KH, Ha CK, Han IW. Estimating the Validity of the Korean Version of Expanded Clinical Dementia Rating(CDR) Scale. J Korean Neurol Assoc 2001;19:585-591.
  22. Reisberg B, Ferris SH, de Leon MJ, Crook T. Global Deterioration Scale(GDS). Psychopharmacol Bull 1988;24:661-663.
  23. Guigoz Y, Lauque S, Vellas BJ. Identifying the elderly at risk for malnutrition. The Mini Nutritional Assessment. Clin Geriatr Med 2002;18:737-757. https://doi.org/10.1016/S0749-0690(02)00059-9
  24. Grundman M, Corey-Bloom J, Jernigan T, Archibald S, Thal LJ. Low body weight in Alzheimer's disease is associated with mesial temporal cortex atrophy. Neurology 1996;46:1585-1591. https://doi.org/10.1212/WNL.46.6.1585
  25. Gillette Guyonnet S, Abellan Van Kan G, Alix E, Andrieu S, Belmin J, Berrut G, Bonnefoy M, Brocker P, Constans T, Ferry M, Ghisolfi-Marque A, Girard L, Gonthier R, Guerin O, Hervy MP, Jouanny P, Laurain MC, Lechowski L, Nourhashemi F, Raynaud-Simon A, Ritz P, Roche J, Rolland Y, Salva T, Vellas B; International Academy on Nutrition and Aging Expert Group. IANA(International Academy on Nutrition and Aging) Expert Group: weight loss and Alzheimer's disease. J Nutr Health Aging 2007;11:38-48.
  26. Barrett-Connor E, Elderstein S, Corey-Bloom J, Wiederholt W. Weight loss precedes dementia in community-dwelling older adults. J Nutr Health Aging 1998;2:113-114.
  27. Johnson DK, Wilkins CH, Morris JC. Accelerated weight loss may precede diagnosis in Alzheimer disease. Arch Neurol 2006;63:1312-1317. https://doi.org/10.1001/archneur.63.9.1312
  28. White HK, McConnell ES, Bales CW, Kuchibhatla M. A 6-month observational study of the relationship between weight loss and behavioral symptoms in institutionalized Alzheimer's disease subjects. J Am Med Dir Assoc 2004;5:89-97. https://doi.org/10.1016/S1525-8610(04)70061-4
  29. Faxen-Irving G, Fereshtehnejad SM, Falahati F, Cedergren L, Goranzon H, Wallman K, Garcia-Ptacek S, Eriksdotter M, Religa D. Body mass index in different dementia disorders: Results from the Swedish dementia quality registry(SveDem). Dement Geriatr Cogn Disord Extra 2014;4:65-75. https://doi.org/10.1159/000360415
  30. Peters R, Peters J, Warner J, Beckett N, Bulpitt C. Alcohol, dementia and cognitive decline in the elderly: a systematic review. Age Ageing 2008;37:505-512. https://doi.org/10.1093/ageing/afn095
  31. Chen D, Luo W, Guo Z, Wu M, Zhou Z. The impact of interaction between alcohol consumption and obesity on incident hypertension. Zhonghua Yu Fang Yi Xue Za Zhi 2015;49:728-732.
  32. Kivipelto M, Helkala EL, Hanninen T, Laakso MP, Hallikainen M, Alhainen K, Soininen H, Tuomilehto J, Nissinen A. Midlife vascular risk factors and late-life mild cognitive impairment: A population-based study. Neurology 2001;56:1683-1689. https://doi.org/10.1212/WNL.56.12.1683
  33. Yaffe K, Barrett-Connor E, Lin F, Grady D. Serum lipoprotein levels, statin use, and cognitive function in older women. Arch Neurology 2002;59:378-384.
  34. Fillit H, Nash DT, Rundek T, Zuckerman A. Cardiovascular risk factors and dementia. Am J Geriatr Pharmacother 2008;6:100-118. https://doi.org/10.1016/j.amjopharm.2008.06.004
  35. Gustafson D, Rothenberg E, Blennow K, Steen B, Skoog I. An 18-year follow-up of overweight and risk of Alzheimer disease. Arch Intern Med 2003;163:1524-1528. https://doi.org/10.1001/archinte.163.13.1524
  36. Wang PN, Yang CL, Lin KN, Chen WT, Chwang LC, Liu HC. Weight loss, nutritional status and physical activity in patients with Alzheimer's disease. A controlled study. J Neurol 2004;251:314-320. https://doi.org/10.1007/s00415-004-0316-4
  37. Vetrivel KS, Thinakaran G. Amyloidogenic processing of beta-amyloid precursor protein in intracellular compartments. Neurology 2006;66:69-73. https://doi.org/10.1212/01.wnl.0000192393.05850.ec
  38. Lee VM, Trojanowski JQ. Mechanisms of parkinson's disease linked to pathological alpha-synuclein: New targets for drug discovery. Neuron 2006;52:33-38. https://doi.org/10.1016/j.neuron.2006.09.026